Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.
Jun 2007 - Cancer Immunol. Immunother.; 56(9):0340-7004 [PMID:17285289]
[Svane IM] [Pedersen AE] [Johansen JS] [Johnsen HE] [Nielsen D] [Kamby C] [Ottesen S] [Balslev E] [Gaarsdal E] [Nikolajsen K] [Claesson MH]

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.
Jun 2004 - Cancer Immunol. Immunother.; 53(7):0340-7004 [PMID:14985857]
[Svane IM] [Pedersen AE] [Johnsen HE] [Nielsen D] [Kamby C] [Gaarsdal E] [Nikolajsen K] [Buus S] [Claesson MH]